Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Beijing Health (Holdings) Limited ( (HK:2389) ) has shared an announcement.
Beijing Health (Holdings) Limited has scheduled a board meeting for 30 March 2026 to review and approve the group’s final results for the financial year ended 31 December 2025. At the same meeting, directors will also consider the possible declaration of a final dividend and address other corporate matters, signaling an upcoming update that may affect shareholders’ expectations on performance and capital returns.
The announcement confirms the governance and decision-making timetable but does not yet disclose any figures or payout levels, leaving investors to await clarity on the company’s earnings trajectory and dividend policy. The formal notice also reinforces transparency obligations under Hong Kong listing rules, as the company prepares to communicate year-end financial performance to the market.
The most recent analyst rating on (HK:2389) stock is a Hold with a HK$0.06 price target. To see the full list of analyst forecasts on Beijing Health (Holdings) Limited stock, see the HK:2389 Stock Forecast page.
More about Beijing Health (Holdings) Limited
Beijing Health (Holdings) Limited is a Hong Kong-listed company incorporated in the Cayman Islands and traded under stock code 2389. The board comprises four executive directors and four independent non-executive directors, reflecting a typical governance structure for a mid-sized listed enterprise in the region.
Average Trading Volume: 2,460,094
Technical Sentiment Signal: Sell
Current Market Cap: HK$424.1M
For detailed information about 2389 stock, go to TipRanks’ Stock Analysis page.